More High Grades at Quebec Property for this 'Top Pick' Gold Miner

The Gold Report - Streetwise Exclusive Articles Fu |

Source: Streetwise Reports   06/30/2018

An Echelon Wealth Partners report explained this company's recently reported assays and why it is a top pick.

Ryan Walker, an analyst with Echelon Wealth Partners, reported in a June 26 research note that new drill results revealed additional high grades and extended the mineralization at the A zone of Wesdome Gold Mines Ltd.'s (WDO:TSX) Kiena Deep discovery in Val d'Or.

As for the results from the latest batch of holes, "visible gold was observed in the majority of the drill holes within predominantly shear zone-hosted quartz veins," Walker relayed. Assays showed "impressive, multiounce, high-grade mineable intervals." For instance, hole 6300 hit 132.1 grams per ton (g/t) gold over 13.2m at a 6.4m true width, and hole 6308 hit 42.6 g/t gold over 12.6m at a 10.4m true width.

Results confirmed the continuity of the mineralized zones and that the "dip of the contact is shallow to the east," Walker clarified. They also suggested "additional potential for downplunge mineralization along the bend or 'kink' in the hosting shear zone."

The A zone remains open along strike in both directions and down dip. Drilling continues with three rigs, with the goals of better delineating the known mineralization and potential extensions, and perhaps discovering new zones. Assays remain pending for 10 other drilled holes.

Along with a steady flow of Kiena assay results (drilling is in progress at the Upper Quartz and VC zones, too), upcoming catalysts for Wesdome include an updated project resource estimate in Q4/18 and improved "production and exploration from the Eagle River underground mine in Ontario," wrote Walker.

He reiterated that Echelon has a Top Pick status, a Speculative Buy rating and a CA$4.40 per share target price on Wesdome. The miner's stock is currently trading at around CA$2.90 per share, "a good entry point" ahead of the near-term catalysts, he added.

Want to read more Energy Report articles like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see a list of recent articles and interviews with industry analysts and commentators, visit our Streetwise Interviews page.

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article.

Disclosures from Echelon Wealth Partners, Wesdome Gold Mines Ltd., June 26, 2018

Echelon Wealth Partners compensates its Research Analysts from a variety of sources. The Research Department is a cost centre and is funded by the business activities of Echelon Wealth Partners including, Institutional Equity Sales and Trading, Retail Sales and Corporate and Investment Banking.

I, Ryan Walker, hereby certify that the views expressed in this report accurately reflect my personal views about the subject securities or issuers. I also certify that I have not, am not, and will not receive, directly or indirectly, compensation in exchange for expressing the specific recommendations or views in this report.

Important Disclosures:
During the last 12 months, has Echelon Wealth Partners Inc. provided financial advice to and/or, either on its own or as a syndicate member, participated in a public offering, or private placement of securities of this issuer? No

During the last 12 months, has Echelon Wealth Partners Inc. received compensation for having provided investment banking or related services to this Issuer? No

( Companies Mentioned: WDO:TSX, )

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.